These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 8212165)

  • 1. The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat.
    Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
    Transplantation; 1993 Sep; 56(3):667-72. PubMed ID: 8212165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplantation; 1993 Oct; 56(4):898-904. PubMed ID: 8212214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prolongation of concordant hamster-to-rat cardiac xenografts by brequinar sodium.
    Cramer DV; Chapman FA; Jaffee BD; Zajac I; Hreha-Eiras G; Yasunaga C; Wu GD; Makowka L
    Transplantation; 1992 Sep; 54(3):403-8. PubMed ID: 1412717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive effect of combination schedules of brequinar with leflunomide or tacrolimus on rat cardiac allotransplantation.
    Antoniou EA; Deroover A; Howie AJ; Chondros K; McMaster P; D'Silva M
    Microsurgery; 1999; 19(2):98-102. PubMed ID: 10188834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
    Wang M; Qu X; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1996 Feb; 61(3):458-64. PubMed ID: 8610361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cyclosporine, mycophenolate mofetil, and Brequinar sodium combination therapy on hamster-to-rat cardiac xenotransplantation.
    Fujino Y; Kawamura T; Hullett DA; Sollinger HW
    Transplantation; 1994 Jan; 57(1):41-6. PubMed ID: 8291113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival.
    Cosenza CA; Cramer DV; Tuso PJ; Chapman FA; Wang HK; Makowka L
    J Heart Lung Transplant; 1994; 13(3):489-97. PubMed ID: 8061026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of allograft survival by combination RS-61443 and DUP-785 therapy.
    Kawamura T; Hullett DA; Suzuki Y; Bechstein WO; Allison AM; Sollinger HW
    Transplantation; 1993 Apr; 55(4):691-4; discussion 694-5. PubMed ID: 8475537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of Brequinar as an immunosuppressive drug for transplantation.
    Makowka L; Sher LS; Cramer DV
    Immunol Rev; 1993 Dec; 136():51-70. PubMed ID: 8132203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.
    Wang J; Xu R; Jin R; Chen Z; Fidler JM
    Transplantation; 2000 Aug; 70(3):447-55. PubMed ID: 10949186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection.
    Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):57-8. PubMed ID: 8516945
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression.
    Shirwan H; Cosenza CA; Wang HK; Wu GD; Makowka L; Cramer DV
    Transplantation; 1994 Apr; 57(7):1072-80. PubMed ID: 8165706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice.
    Tu Y; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1995 Jan; 59(2):177-83. PubMed ID: 7839437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
    Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
    Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of vascularized allograft and xenograft rejection in rodents by brequinar sodium.
    Cramer DV; Chapman FA; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):23-8. PubMed ID: 8516938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brequinar sodium: monitoring immunosuppressive activity.
    Eiras-Hreha G; Cramer DV; Cosenza C; Chapman FA; Mills L; Cajulis E; Hill D; Jones E; Zajac I; Jaffee B
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):32-6. PubMed ID: 8516940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synergistic interactions in vitro and in vivo of brequinar sodium with cyclosporine or rapamycin alone and in triple combination.
    Kahan BD; Tejpal N; Gibbons-Stubbers S; Tu Y; Wang M; Stepkowski S; Chou TC
    Transplantation; 1993 Apr; 55(4):894-900. PubMed ID: 8475566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I safety and pharmacokinetic studies of brequinar sodium after single ascending oral doses in stable renal, hepatic, and cardiac allograft recipients.
    Joshi AS; King SY; Zajac BA; Makowka L; Sher LS; Kahan BD; Menkis AH; Stiller CR; Schaefle B; Kornhauser DM
    J Clin Pharmacol; 1997 Dec; 37(12):1121-8. PubMed ID: 9506007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.